ABG Analytics logo
Get updates

Biogen Inc (NASDAQ: BIIB)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 11/15/2019
Closing price: 282.27
Support price level: $255.14
Resistance price level: N/A
Relative strength index (14-day RSI) 37.2
Beta 1.38
  • BIIB is one of this month's top performers with a return of 28.3 percent, beating 90 percent of stocks in the S&P-100.

  • Down 3.7 percent, BIIB is one of this week's biggest decliners.

  • BIIB is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 41.5%.

  • Volatility is forecast to fall over the next month.

  • BIIB is above its 200-day moving average, providing a measure of support for long positions.

  • Price broke above prior resistance level - a short-term bullish signal.

Low High Price as % of Range
$216.71 $338.96 59.1%
200 day 50 day 20 day 10 day
$251.38 $252.47 $286.42 $287.96
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
37.7% 38.0% 41.5% 37.8%
There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than:
  • 11.3% in the next week.

  • 21.4% in the next month.

  • 86.0% in the next year.